DNDN

Dendreon Corporation News Headlines

$1.5
*  
0.08
5.63%
Get DNDN Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading DNDN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dendreon: Q1 Earnings Preview
4/25/2011 4:23:00 PM - Seeking Alpha

6 Stocks Whose Earnings Are Expected to Increase Sharply
4/22/2011 1:58:00 AM - Seeking Alpha

Dendreon Is Way Undervalued
4/21/2011 2:21:00 PM - Seeking Alpha

Beyond Provenge: Dendreon Is Too Expensive for Value, Growth Investors
4/21/2011 8:14:00 AM - Seeking Alpha

Dendreon's Price Run May Be in Anticipation of Stronger Earnings
4/19/2011 12:07:00 PM - Seeking Alpha

The 2011 ASCO Trades
4/14/2011 6:21:00 PM - Seeking Alpha

Johnson & Johnson: Potential M&A Targets to Recharge Growth, Divert Investor Attention
4/13/2011 5:55:00 AM - Seeking Alpha

Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
4/11/2011 1:06:00 PM - Seeking Alpha

Why Provenge Could Be a $10 Billion Drug for Dendreon
4/11/2011 5:18:00 AM - Seeking Alpha

Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
4/8/2011 3:59:00 PM - Seeking Alpha

Time to Consider Xenoport Among Biotech Strategies for Your Portfolio
4/8/2011 12:26:00 PM - Seeking Alpha

8 Promising Biotech Buyout Targets if Their Products Can Deliver
4/8/2011 8:44:00 AM - Seeking Alpha

Vical: A Biotech Flying Under the Radar
4/6/2011 3:58:00 PM - Seeking Alpha

George Soros's (Extremely Successful) Long-Term Holdings
4/5/2011 7:49:00 AM - Seeking Alpha

Dendreon: Mammoth Potential Despite Drama
4/4/2011 7:48:00 AM - Seeking Alpha

Dendreon: A Pipeline That's the Envy of Big Pharma
4/4/2011 7:03:00 AM - Seeking Alpha

46 Favorites of Hedge Fund Managers
4/1/2011 9:18:00 AM - Seeking Alpha

Quiet End to Tumultuous Quarter for Wall Street
3/31/2011 3:35:00 PM - Fox Business

Stocks Seek Direction as Oil Jumps
3/31/2011 8:39:00 AM - Fox Business

Stocks Gyrate as Traders Eye Oil, Data
3/31/2011 8:39:00 AM - Fox Business

Why Dendreon Will Power Ahead Now
3/31/2011 4:59:00 AM - Seeking Alpha

Similarities Between the First Two Active Immunotherapies in Cancer
3/30/2011 7:44:00 PM - Seeking Alpha

CMS Draft Guidance on Dendreon's Provenge Could Be Imminent
3/29/2011 1:27:00 PM - Seeking Alpha

Ipilimumab Approval Highlights Active Immunotherapy Renaissance
3/27/2011 8:28:00 AM - Seeking Alpha

Amarin Example Shows Common Sense Is Crucial in Navigating Biotech Sector Volatility
3/23/2011 10:24:00 AM - Seeking Alpha